Automating MEDITECH Infusion Therapy Prior Authorization

Navigating **MEDITECH Infusion Therapy prior authorization** demands precision and adaptability, especially given the complex site-of-service requirements for specialty drugs.

Revenue cycle leaders and prior authorization coordinators face significant challenges in securing timely approvals for infusion therapies. Delays impact patient care and financial health. Klivira provides a robust solution to automate the prior authorization process, integrating seamlessly with your MEDITECH environment.

The Nuance of MEDITECH Integration for Infusion Therapy

MEDITECH's diverse product lines—from the modern Expanse to legacy Magic, C/S, and 6.x environments—present varied integration surfaces. Automating infusion therapy prior authorization requires an adaptable approach that accounts for these differences, leveraging the most effective pathways available at each institution. Klivira's platform is engineered to navigate this complexity, ensuring consistent data flow regardless of your specific MEDITECH deployment.

Streamlining Infusion Therapy Order Entry and PA Triggers in MEDITECH

Within MEDITECH, clinicians typically initiate infusion therapy orders through the "Orders activity" module, particularly in Expanse. These orders, once placed, serve as the primary trigger for prior authorization workflows. Klivira intercepts these events, identifying the specific drug, dosage, and proposed site of service (e.g., home, outpatient clinic, hospital outpatient department) to initiate the appropriate payer review process.

Leveraging Clinical Context from MEDITECH for Robust PA Submissions

Successful prior authorization for infusion therapy hinges on comprehensive clinical documentation. Klivira extracts relevant patient data from MEDITECH's "Patient Summary / Storyboard" and "Documentation" modules, including clinical notes, diagnoses, and treatment plans. This detailed clinical context is then compiled into a payer-ready packet, ensuring all necessary information supports the medical necessity of the requested infusion.

Klivira's Integration Pathways with MEDITECH

MEDITECH Expanse FHIR R4 APIs: Leveraging US Core resources for secure, standardized data exchange on modern deployments.
SMART App Launch: Enabling seamless, context-aware application launch directly from the Expanse clinical desktop.
HL7 v2 Interfaces: Ensuring connectivity with legacy MEDITECH Magic, C/S, and 6.x environments for ADT, ORM/ORU, and MDM messages.
Greenfield Workspace: Utilizing MEDITECH's developer environment for API access and integration project management.

Automating Site-of-Service Review for Infusion Therapy

A critical dimension of infusion therapy prior authorization is the site-of-service review, where payers evaluate the most appropriate and cost-effective setting for treatment. Klivira's platform automates the submission of site-specific clinical criteria, proactively addressing payer requirements and reducing administrative burden associated with these complex determinations.

Real-time PA Status and Write-back to MEDITECH

Klivira facilitates the continuous update of prior authorization statuses directly within your MEDITECH system. While FHIR write-back capabilities vary by MEDITECH product line and require customer-specific verification, Klivira can deposit PA status and approval documents into "Documentation" attachments or route notifications to "Surveillance / Worklists." This ensures clinicians and PA coordinators have immediate access to the latest authorization information.

Frequently asked questions

How does Klivira handle the different MEDITECH product lines for infusion therapy prior authorizations?

Klivira is designed with an adaptable integration strategy. For MEDITECH Expanse, we leverage modern FHIR R4 APIs and SMART App Launch. For legacy systems like Magic, C/S, and 6.x, we utilize established HL7 v2 interfaces to ensure comprehensive data exchange for infusion therapy PA workflows.

What specific clinical documentation does Klivira pull from MEDITECH for infusion PA submissions?

For infusion therapy prior authorizations, Klivira extracts critical clinical context from MEDITECH's "Patient Summary / Storyboard" and "Documentation" modules. This includes physician notes, diagnosis codes, medication lists, and other supporting clinical evidence necessary to demonstrate medical necessity to payers.

Can Klivira help with site-of-service reviews for infusion therapy?

Yes, site-of-service review is a major component of infusion therapy prior authorization. Klivira's platform is configured to capture and submit the specific clinical and logistical data required by payers to determine the appropriate care setting, whether it's home infusion, an outpatient clinic, or a hospital outpatient department.

How does Klivira update the prior authorization status back into MEDITECH?

Klivira integrates PA status updates into MEDITECH by depositing approval letters and status changes as "Documentation" attachments within the patient chart. For workflow visibility, notifications can also be routed to "Surveillance / Worklists." Specific write-back capabilities via FHIR for real-time status updates are verified per customer's MEDITECH Expanse configuration.

Does Klivira integrate directly with payer portals and X12 278 transactions for infusion therapy?

Yes, Klivira automates the submission of infusion therapy prior authorizations through direct integrations with payer portals and via the X12 278 electronic prior authorization standard. This multi-channel approach ensures comprehensive coverage and efficient processing for a wide range of payers.